Business Description
Cresco Labs Inc
NAICS : 325410
SIC : 3741
ISIN : CA22587M1068
Total Employee Number:
2,900Description
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.75 | |||||
Debt-to-EBITDA | 33.16 | |||||
Interest Coverage | 1.24 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.99 | |||||
Beneish M-Score | -2.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.8 | |||||
3-Year EPS without NRI Growth Rate | 34.2 | |||||
3-Year Book Growth Rate | -22.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 18.43 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.32 | |||||
9-Day RSI | 39.19 | |||||
14-Day RSI | 41.65 | |||||
3-1 Month Momentum % | -8.08 | |||||
6-1 Month Momentum % | -24.4 | |||||
12-1 Month Momentum % | 90.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.51 | |||||
Quick Ratio | 1.41 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 109.43 | |||||
Days Sales Outstanding | 23.36 | |||||
Days Payable | 19.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.1 | |||||
Shareholder Yield % | 25.12 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 50.1 | |||||
Operating Margin % | 11.62 | |||||
Net Margin % | -20.93 | |||||
EBITDA Margin % | 2.75 | |||||
FCF Margin % | -0.7 | |||||
OCF Margin % | 5.71 | |||||
ROE % | -33.05 | |||||
ROA % | -10.41 | |||||
ROIC % | 6.61 | |||||
3-Year ROIIC % | -8.68 | |||||
ROC (Joel Greenblatt) % | -6.86 | |||||
ROCE % | -3.16 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.47 | |||||
PB Ratio | 0.94 | |||||
Price-to-Operating-Cash-Flow | 8.24 | |||||
EV-to-EBIT | -20.73 | |||||
EV-to-EBITDA | 44.05 | |||||
EV-to-Forward-EBITDA | 7.59 | |||||
EV-to-Revenue | 1.22 | |||||
EV-to-Forward-Revenue | 0.9 | |||||
EV-to-FCF | -190.46 | |||||
Price-to-GF-Value | 0.84 | |||||
Price-to-Projected-FCF | 2.74 | |||||
Earnings Yield (Greenblatt) % | -4.83 | |||||
FCF Yield % | -1.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cresco Labs Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 551.23 | ||
| EPS (TTM) (€) | -0.326 | ||
| Beta | 2.5486 | ||
| 3-Year Sharpe Ratio | 0.21 | ||
| 3-Year Sortino Ratio | 0.42 | ||
| Volatility % | 145.97 | ||
| 14-Day RSI | 41.65 | ||
| 14-Day ATR (€) | 0.023818 | ||
| 20-Day SMA (€) | 0.69195 | ||
| 12-1 Month Momentum % | 90.5 | ||
| 52-Week Range (€) | 0.4 - 1.9 | ||
| Shares Outstanding (Mil) | 370.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cresco Labs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cresco Labs Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 08:30 | In 121 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 120 days | ||
| General meeting for 2026 | 2026-09-16 12:00 | In 71 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-07 08:30 | In 31 days | ||
| Second quarter earnings results for 2026 | 2026-08-07 | In 30 days | ||
| First quarter earnings conference call for 2026 | 2026-05-08 08:30 | 0.92 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-08 | 0.92 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-05 08:30 | 0.77 (+0.00%) | ||
| Annual report for 2025 | 2026-03-05 | 0.77 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-05 | 0.77 (+0.00%) |
Show
Entries
Cresco Labs Inc Frequently Asked Questions
What is Cresco Labs Inc(FRA:6CQ)'s stock price today?
The current price of FRA:6CQ is €0.66. The 52 week high of FRA:6CQ is €1.90 and 52 week low is €0.40.
When is next earnings date of Cresco Labs Inc(FRA:6CQ)?
The next earnings date of Cresco Labs Inc(FRA:6CQ) is 2026-08-07 Est..
Does Cresco Labs Inc(FRA:6CQ) pay dividends? If so, how much?
Cresco Labs Inc(FRA:6CQ) does not pay dividend.
Press Release
Articles on Cresco Labs Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers